Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.Journal of Immunological Sciences|March 30, 2023
Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic ChangesAda Alice Dona, James F Sanchez, Joycelynne M Palmer, et al.Leukemia|February 22, 2020
Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myelomaAmrita Krishnan, Prashant Kapoor, Joycelynne M Palmer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple MyelomaXiuli Wang, Miriam Walter, Ryan Urak, et al.Leukemia & Lymphoma|April 10, 2020
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 studyMichael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, et al.Biorxiv : the Preprint Server for Biology|March 13, 2023
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemiaMariam Murtadha, Miso Park, Yinghui Zhu, et al.International Journal of Radiation Oncology, Biology, Physics|June 13, 2021
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation StudiesDarren Zuro, Srideshikan Sargur Madabushi, Jamison Brooks, et al.Blood|January 6, 2018
Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myelomaEnrico Caserta, Junie Chea, Megan Minnix, et al.Journal of Hematology & Oncology|January 19, 2025
Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effectsAda Alice Dona, Theophilus Tandoh, Lokesh Nigam, et al.Molecular Therapy Oncolytics|March 19, 2021
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivoJayeeta Ghose, Ada Dona, Mariam Murtadha, et al.Pageof 6